Publications

Journal Article
Research Support, U.S. Gov't, P.H.S.
Ppublish 292 citations
Electronic publication date
March 1, 1980

View on Pubmed.gov 6245210 | View on doi.org 10.1021/jm00177...

A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.

Search for publications in this journal J Med Chem - 23(3):233-4

Abstract

No abstract provided.

References

No references provided.

Cited by 292 citations (total)

Journal Article Research Support, U.S. Gov't, P.H.S.

Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo.

Electronic publication date November 1, 1996

Search for publications in this journal Neurochem Res

X H Chen [...] M W Adler et al.

We examined whether mu-antisense (AS) oligodeoxynucleotide (oligo) treatment can be used in a manner similar to the mu-selective irreversible antagonist...

Journal Article Research Support, N.I.H., Extramural

Chronic suppression of μ-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats.

Electronic publication date December 14, 2010

Search for publications in this journal Int J Obes (Lond)

N R Lenard [...] H-R Berthoud et al.

OBJECTIVE

To test the hypothesis that micro-opioid receptor signaling in the nucleus accumbens contributes to hedonic (over)eating and obesity. To investigate...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Substances